Challenging the FDA's Authority to Regulate Autologous Adult Stem Cells for Therapeutic Use: Celltex Therapeutics' Partnership with RNL Bio, Substantial Medical Risks, and the Implications of United States v. Regenerative Sciences

Authors

Katherine Drabiak-Syed

Recommended Citation

Katherine Drabiak-Syed, Challenging the FDA's Authority to Regulate Autologous Adult Stem Cells for Therapeutic Use: Celltex Therapeutics' Partnership with RNL Bio, Substantial Medical Risks, and the Implications of United States v. Regenerative Sciences, 23 Health Matrix 493 (2013)
Available at: https://scholarlycommons.law.case.edu/healthmatrix/vol23/iss2/19